PUBLISHER: The Business Research Company | PRODUCT CODE: 1669376
PUBLISHER: The Business Research Company | PRODUCT CODE: 1669376
Artificial Intelligence In Epidemiology Global Market Report 2025
The application of artificial intelligence (AI) in epidemiology involves utilizing AI techniques and tools to enhance and optimize epidemiological research as well as public health interventions. AI in epidemiology aids in the analysis of extensive datasets, the identification of patterns and trends, support for decision-making processes, and the prediction of disease outbreaks to facilitate disease prevention, monitoring, and control.
The primary components of artificial intelligence in epidemiology consist of software and services. Software encompasses a set of programs, instructions, and data that enable a computer or other electronic device to perform specific tasks or operations. Software plays a pivotal role in the implementation of AI in epidemiology, facilitating the analysis of large datasets, modeling the spread of diseases, and making predictions for public health interventions. These software applications are deployed in web-based and cloud-based modes for purposes such as infection prediction and forecasting, disease surveillance, and syndromic surveillance. End-users of such applications include government and state agencies, research laboratories, pharmaceutical and biotechnology companies, as well as healthcare providers.
The artificial intelligence in epidemiology research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in epidemiology market statistics, including the artificial intelligence in epidemiology industry's global market size, regional shares, competitors with an artificial intelligence in epidemiology market share, detailed artificial intelligence in epidemiology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in epidemiology industry. This artificial intelligence in epidemiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The artificial intelligence in epidemiology market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.84 billion in 2025 at a compound annual growth rate (CAGR) of 28.0%. The growth in the historic period can be attributed to emergence of big data, globalization and travel, public health surveillance needs, outbreak response challenges, emergence of novel pathogens
The artificial intelligence in epidemiology market size is expected to see exponential growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to data integration challenges, population growth, global health security investments, digital health adoption, one health approach, digital contact tracing. Major trends in the forecast period include advancements in computational power, technological innovations in data collection, collaboration with technology companies, real-time data sharing platforms, advancements in ai algorithms, advancements in remote sensing technologies, blockchain for epidemiological data security.
The anticipated increase in the prevalence of chronic diseases is expected to drive the growth of artificial intelligence in the epidemiology market in the future. Chronic diseases are health conditions that persist or have long-lasting effects, typically lasting for three months or more and often worsening over time. AI plays a crucial role in various aspects of chronic disease epidemiology, including risk prediction, modeling disease progression, early detection, and diagnosis. For example, a May 2023 report from The United Nations (UN) stated that chronic diseases account for seven out of 10 deaths in the US, causing over 1.7 million deaths annually. Therefore, the rising burden of chronic diseases is projected to fuel the growth of artificial intelligence in the epidemiology market.
The growing usage of telemedicine is expected to drive the growth of artificial intelligence in the epidemiology market in the coming years. Telemedicine refers to the delivery of medical services remotely through telecommunications technology, involving the transmission of medical information between patients and healthcare providers, typically via audio, video, or other communication methods. The combination of telemedicine and artificial intelligence (AI) in epidemiology can create a powerful synergy that enables a proactive and data-driven approach to addressing public health issues. It enhances the ability to efficiently monitor, assess, and respond to health-related data, particularly during outbreaks or pandemics. For example, in February 2023, Rock Health, a US-based seed fund supporting digital health startups, reported in a survey that 80% of respondents had accessed telemedicine at some point in their lives in 2022, marking an 8-percentage point increase from 72% in 2021. Telemedicine use also increased among women, with 82% of female respondents indicating they had utilized telemedicine, a 9-percentage point rise from 2021. Therefore, the increasing usage of telemedicine is driving growth in the artificial intelligence in epidemiology market.
A notable trend gaining popularity in the artificial intelligence in epidemiology market is the development of specialized AI-based technologies for disease management. Key companies in this market are focusing on creating innovative technologies, such as AI-driven imaging platforms for disease management, to solidify their market position. For instance, in April 2023, Twinn.health, a US-based company specializing in fitness, AI, and machine learning, launched an AI-driven imaging platform for the early detection of age-related diseases. This platform, the first to incorporate magnetic resonance imaging (MRI) data for evaluating frailty risk, serves as a potent tool for early intervention and prevention by detecting age-related disorders earlier than traditional molecular signals and aiding in their management at an early stage.
Major companies in the artificial intelligence in epidemiology market are concentrating on innovative products, including stroke scoring tools, to better cater to the needs of their existing consumers. Stroke scoring tools are clinical assessments used by healthcare professionals to quickly and objectively evaluate the severity of a stroke. For example, in November 2022, Koninklijke Philips N.V., a Netherlands-based medical technology company, introduced the AI-powered CT ASPECT Scoring tool. This tool, applied to non-contrast CT scans, detects early indicators of brain infarction in the treatment of ischemic stroke patients. The program employs AI to automatically identify ASPECTS brain regions and generates an ASPECT score communicated directly to the Picture Archiving and Communication System (PACS). Philips also unveiled its next-generation Advanced Visualization Workspace, including a new cardiac MR Suite with a redesigned workflow and user interface.
In January 2022, Glooko Inc., a US-based digital health company specializing in diabetes management solutions, acquired Xbird for an undisclosed amount. With this acquisition, Glooko aims to reinforce its commitment to machine learning and personalized digital coaching for patients with chronic conditions. Xbird, a Berlin-based company engaged in health AI, focuses on developing JITAI (Just in Time Adaptive Intervention) technologies for proactive healthcare interventions and disease surveillance.
Major companies operating in the artificial intelligence in epidemiology market include Apple Inc., Alphabet Inc., Microsoft Corporation, Facebook Inc., Roche Holding AG, Pfizer Inc., Johnson & Johnson Services Inc., Amazon Web Services Inc., General Electric Company, Google LLC, Intel Corporation, IBM Corporation, Merck & Co. Inc., Novartis International AG, Sanofi S.A, Bristol Myers Squibb Company, AstraZeneca PLC, Oracle Corporation, GlaxoSmithKline plc, NVIDIA Corporation, Bayer Healthcare, Siemens Healthineers AG, Cogniant Technology Solutions Corporation, Koninklijke Philips N.V., SAS Institute Inc., Epic Systems Corporation, Cerner Corporation, eClinicalWorks LLC, Meditech, Komodo Health, Metabiota Inc.
North America was the largest region in the artificial intelligence in epidemiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in epidemiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the artificial intelligence in epidemiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The artificial intelligence in epidemiology market consists of revenues earned by entities by providing disease surveillance and management, predictive modeling, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in epidemiology market also includes sales of real-time monitoring systems and image analysis systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence In Epidemiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence in epidemiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial intelligence in epidemiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in epidemiology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Component: Software; Services
- 2) By Deployment: Web-Based; Cloud-Based
- 3) By Application: Infection Prediction And Forecasting; Disease And Syndromic Surveillance
- 4) By End-Use: Government And State Agencies; Research Laboratories; Pharmaceutical And Biotechnology Companies; Healthcare Providers
- Subsegments:
- 1) By Software: Data Analytics Platforms; Predictive Modeling Tools; Geographic Information Systems (GIS); Surveillance Systems; Reporting And Visualization Tools
- 2) By Services: Consulting Services; Implementation And Integration Services; Data Management And Support Services; Training And Capacity Building Services
- Companies Mentioned: Apple Inc.; Alphabet Inc.; Microsoft Corporation; Facebook Inc.; Roche Holding AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Artificial Intelligence In Epidemiology Market Characteristics
3. Artificial Intelligence In Epidemiology Market Trends And Strategies
4. Artificial Intelligence In Epidemiology Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Artificial Intelligence In Epidemiology Growth Analysis And Strategic Analysis Framework
- 5.1. Global Artificial Intelligence In Epidemiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Artificial Intelligence In Epidemiology Market Growth Rate Analysis
- 5.4. Global Artificial Intelligence In Epidemiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Artificial Intelligence In Epidemiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Artificial Intelligence In Epidemiology Total Addressable Market (TAM)
6. Artificial Intelligence In Epidemiology Market Segmentation
- 6.1. Global Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Software
- Services
- 6.2. Global Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Web-Based
- Cloud-Based
- 6.3. Global Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Infection Prediction And Forecasting
- Disease And Syndromic Surveillance
- 6.4. Global Artificial Intelligence In Epidemiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Government And State Agencies
- Research Laboratories
- Pharmaceutical And Biotechnology Companies
- Healthcare Providers
- 6.5. Global Artificial Intelligence In Epidemiology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Data Analytics Platforms
- Predictive Modeling Tools
- Geographic Information Systems (GIS)
- Surveillance Systems
- Reporting And Visualization Tools
- 6.6. Global Artificial Intelligence In Epidemiology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Consulting Services
- Implementation And Integration Services
- Data Management And Support Services
- Training And Capacity Building Services
7. Artificial Intelligence In Epidemiology Market Regional And Country Analysis
- 7.1. Global Artificial Intelligence In Epidemiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Artificial Intelligence In Epidemiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Artificial Intelligence In Epidemiology Market
- 8.1. Asia-Pacific Artificial Intelligence In Epidemiology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Artificial Intelligence In Epidemiology Market
- 9.1. China Artificial Intelligence In Epidemiology Market Overview
- 9.2. China Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Artificial Intelligence In Epidemiology Market
- 10.1. India Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Artificial Intelligence In Epidemiology Market
- 11.1. Japan Artificial Intelligence In Epidemiology Market Overview
- 11.2. Japan Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Artificial Intelligence In Epidemiology Market
- 12.1. Australia Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Artificial Intelligence In Epidemiology Market
- 13.1. Indonesia Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Artificial Intelligence In Epidemiology Market
- 14.1. South Korea Artificial Intelligence In Epidemiology Market Overview
- 14.2. South Korea Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Artificial Intelligence In Epidemiology Market
- 15.1. Western Europe Artificial Intelligence In Epidemiology Market Overview
- 15.2. Western Europe Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Artificial Intelligence In Epidemiology Market
- 16.1. UK Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Artificial Intelligence In Epidemiology Market
- 17.1. Germany Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Artificial Intelligence In Epidemiology Market
- 18.1. France Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Artificial Intelligence In Epidemiology Market
- 19.1. Italy Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Artificial Intelligence In Epidemiology Market
- 20.1. Spain Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Artificial Intelligence In Epidemiology Market
- 21.1. Eastern Europe Artificial Intelligence In Epidemiology Market Overview
- 21.2. Eastern Europe Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Artificial Intelligence In Epidemiology Market
- 22.1. Russia Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Artificial Intelligence In Epidemiology Market
- 23.1. North America Artificial Intelligence In Epidemiology Market Overview
- 23.2. North America Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Artificial Intelligence In Epidemiology Market
- 24.1. USA Artificial Intelligence In Epidemiology Market Overview
- 24.2. USA Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Artificial Intelligence In Epidemiology Market
- 25.1. Canada Artificial Intelligence In Epidemiology Market Overview
- 25.2. Canada Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Artificial Intelligence In Epidemiology Market
- 26.1. South America Artificial Intelligence In Epidemiology Market Overview
- 26.2. South America Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Artificial Intelligence In Epidemiology Market
- 27.1. Brazil Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Artificial Intelligence In Epidemiology Market
- 28.1. Middle East Artificial Intelligence In Epidemiology Market Overview
- 28.2. Middle East Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Artificial Intelligence In Epidemiology Market
- 29.1. Africa Artificial Intelligence In Epidemiology Market Overview
- 29.2. Africa Artificial Intelligence In Epidemiology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Artificial Intelligence In Epidemiology Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Artificial Intelligence In Epidemiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Artificial Intelligence In Epidemiology Market Competitive Landscape And Company Profiles
- 30.1. Artificial Intelligence In Epidemiology Market Competitive Landscape
- 30.2. Artificial Intelligence In Epidemiology Market Company Profiles
- 30.2.1. Apple Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Facebook Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
31. Artificial Intelligence In Epidemiology Market Other Major And Innovative Companies
- 31.1. Pfizer Inc.
- 31.2. Johnson & Johnson Services Inc.
- 31.3. Amazon Web Services Inc.
- 31.4. General Electric Company
- 31.5. Google LLC
- 31.6. Intel Corporation
- 31.7. IBM Corporation
- 31.8. Merck & Co. Inc.
- 31.9. Novartis International AG
- 31.10. Sanofi S.A
- 31.11. Bristol Myers Squibb Company
- 31.12. AstraZeneca PLC
- 31.13. Oracle Corporation
- 31.14. GlaxoSmithKline plc
- 31.15. NVIDIA Corporation
32. Global Artificial Intelligence In Epidemiology Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Artificial Intelligence In Epidemiology Market
34. Recent Developments In The Artificial Intelligence In Epidemiology Market
35. Artificial Intelligence In Epidemiology Market High Potential Countries, Segments and Strategies
- 35.1 Artificial Intelligence In Epidemiology Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Artificial Intelligence In Epidemiology Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Artificial Intelligence In Epidemiology Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
